Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations

Author： Krekels Elke HJ   Anker John N van den   Baiardi Paola   Cella Massimo   Cheng Katharine Y   Gibb Diana M   Green Hannah   Iolascon Achille   Jacqz-Aigrain Evelyne M   Knibbe Catherijne AJ   Santen Gijs WE   Schaik Ron HN van   Tibboel Dick   Pasqua Oscar E Della  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.8, Iss.12, 2007-08, pp. : 1787-1799

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 Pharmacogenetics in Drug Development: In Vitro Studies and Clinical Consequences

By  

Current Drug Metabolism, Vol. 3, Iss. 3, 2002-06 ,pp. : 289-309

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics: Development Issues and Solutions for Safe and Effective Medicines

By Arnold Hans Peter   McHale Duncan  

Pharmacogenomics, Vol. 7, Iss. 2, 2006-03 ,pp. : 149-155

Future Medicine

Access to resources Recommend Favorite

Pipeline Pharmacogenetics: A Novel Approach to Integrating Pharmacogenetics into Drug Development

By  

Current Pharmaceutical Design, Vol. 15, Iss. 32, 2009-11 ,pp. : 3754-3763

Bentham Science Publishers

Access to resources Recommend Favorite

Incentives for paediatric drug development in Europe

By  

Inpharma, Vol. 1, Iss. 1506, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Regulatory aspects of integration of pharmacogenetics into drug development

By R S.R.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 67-69

Adis International

Access to resources Recommend Favorite